Cargando…
Mutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is a genetic cardiac disease, which affects the structure of heart muscle tissue. The clinical symptoms include arrhythmias, progressive heart failure, and even sudden cardiac death but the mutation carrier can also be totally asymptomatic. To date, over 1400 mutati...
Autores principales: | Ojala, Marisa, Prajapati, Chandra, Pölönen, Risto-Pekka, Rajala, Kristiina, Pekkanen-Mattila, Mari, Rasku, Jyrki, Larsson, Kim, Aalto-Setälä, Katriina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707351/ https://www.ncbi.nlm.nih.gov/pubmed/27057166 http://dx.doi.org/10.1155/2016/1684792 |
Ejemplares similares
-
Fluorescent hiPSC-derived MYH6-mScarlet cardiomyocytes for real-time tracking, imaging, and cardiotoxicity assays
por: Maria Cherian, Reeja, et al.
Publicado: (2022) -
HiPSC-derived cardiomyocyte to model Brugada syndrome: both asymptomatic and symptomatic mutation carriers reveal increased arrhythmogenicity
por: Penttinen, Kirsi, et al.
Publicado: (2023) -
CytoSpectre: a tool for spectral analysis of oriented structures on cellular and subcellular levels
por: Kartasalo, Kimmo, et al.
Publicado: (2015) -
hiPSC-Derived Cardiomyocyte Model of LQT2 Syndrome Derived from Asymptomatic and Symptomatic Mutation Carriers Reproduces Clinical Differences in Aggregates but Not in Single Cells
por: Shah, Disheet, et al.
Publicado: (2020) -
Cardiac Differentiation of Pluripotent Stem Cells
por: Rajala, Kristiina, et al.
Publicado: (2011)